We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

3 top FTSE 100 shares I’d buy in July

These FTSE 100 shares should perform well in the future despite today’s uncertain outlook, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Should you be buying shares when the economic outlook is so uncertain? Absolutely! I’ve found a number of FTSE 100 shares that I think will deliver strong returns to long-term investors from current levels.

Healthcare heavyweight

If you’re building a diversified, long-term portfolio, I think you need to have some exposure to the healthcare sector. It’s an essential global business for which I believe demand will only grow.

My top FTSE 100 pick in this sector is pharmaceutical giant GlaxoSmithKline (LSE: GSK). Alongside its prescription medicine and vaccine businesses, the group also has a large consumer healthcare business — home to brands such as Sensodyne and Nicorette.

Glaxo plans to seperate its consumer business into a new company over the next couple of years. This will dividen the group into two smaller and more focused businesses. I think this will improve their growth potential — good news for shareholders.

The GSK share price has now fallen by nearly 15% from the highs seen earlier this year. The shares now trade on about 13.5 times forecast earnings, with a 5% dividend yield. I think this FTSE 100 share is priced to buy.

A FTSE 100 share for tech investors

Big tech stocks are rare in the UK. One exception is cyber security software group Avast (LSE: AVST). This Prague-based firm only floated on the London market in 2018, but its continued growth has already lifted it into the FTSE 100. I think there could be more to come.

Avast’s core anti-virus product has a free version, which the firm uses to recruit users to whom it can sell additional services. The group also has a corporate business. This might sound like a small operation but it’s not — Avast has over 435m active users and generated revenue of $873m in 2019.

Operating profit margins are high, at around 40%. Cash generation is good too, which means the group’s after-tax profits are reliably converted into spare cash. The only criticism I’d make is that the firm’s growth rate is relatively low — adjusted profits rose by just 8% last year.

Despite this, I think Avast’s strong financial performance and large customer base should support continued growth. The shares currently trade on about 20 times forecast earnings, with a dividend yield of around 2.1%. I think that’s a fair price to pay for this high quality FTSE 100 share.

A fashion stock you can trust

When you invest in a company there’s always an element of risk. As outsiders we never know everything about a business. One company that tries hard to provide a level playing field is retailer Next (LSE: NXT), which is known for the quality of its financial reporting.

The bad news is that Next’s management expect sales to fall by between 30% and 40% this year. As a result, pre-tax profits are expected to fall from £728m last year to a maximum of £150m.

However, there’s good news too. Careful management means that the group’s financial position remains very strong. Net debt is actually expected to fall this year.

Another attraction is that broker forecasts suggest profits will bounce back quickly next year. If they’re correct, then this FTSE 100 share now trades on just 13 times forecast earnings.

Next is a highly profitable business with an excellent track record of shareholder returns. I’d rate the shares as a buy at this level.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Next. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Could Greggs shares bounce back and pull a Rolls-Royce?

It may seem odd to compare a major aerospace engineer to a bakery chain, but Greggs shares currently exhibit a…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

Should investors consider buying Palantir stock after its stellar earnings?

Palantir stock fell today after yesterday’s impressive quarterly earnings results. Muhammad Cheema looks at whether investors should consider buying some.

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

A huge opportunity for growth investors looking for stocks to buy in May?

A quality company showing signs of coming out of a cyclical downturn is at the top of Stephen Wright’s list…

Read more »

Close-up of British bank notes
Investing Articles

£8,580 invested in Rolls-Royce shares shares 5 years ago is now worth…

Rolls-Royce shares have been suffering from Middle East strife fallout, but analysts aren't being dissuaded from their rosy outlook.

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

£7,500 invested in Santander shares 3 years ago is now worth…

Ben McPoland asks whether Santander shares are still worth considering after a blistering hot run over the past three years.

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

1 of the best dividend shares to consider as UK dividend forecasts surge!

Dividends from UK shares surged 21.1% in Q1. The question is, can London stocks keep paying impressive dividends as earnings…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

National Grid shares: a classic sleep-well stock for uncertain markets?

Andrew Mackie analyses National Grid shares and explains why he sees more than just income in a world driven by…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Ever wondered why some FTSE shares have such high dividend yields?

Christopher Ruane explains that FTSE shares may offer high yields for all sorts of reasons. A high yield can be…

Read more »